Benzinga | Aug 17, 2020 07:10AM EDT

HC Wainwright & Co. Upgrades aTyr Pharma to Buy, Announces $13 Price Target

HC Wainwright & Co. analyst Joseph Pantginis upgrades aTyr Pharma (NASDAQ:LIFE) from Neutral to Buy and announces $13 price target.